Stroke
Conditions
Interventions
Experimental group:rTMS + rPMS
Control Group:rTMS + rPMS sham stimulation
Sponsors
The Affiliated Third Hospital of Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
25 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Meet the stroke criteria established in 2019, confirmed by CT or MRI as cerebral infarction or cerebral hemorrhage; 2. First onset, hemiparesis of one limb with upper limb motor dysfunction; 3. Duration of disease from 2 weeks to 6 months; 4. Aged 25-75 years; 5. Upper limb Brunnstrom stage between stage I-V, upper limb and hand MAS <= grade 2; 6. Stable vital signs, able to cooperate with treatment and assessment; 7. Patients or their families agree to participate in the trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. The following contraindications to transcranial magnetic therapy: intracranial metal implants, cochlear implants, magnetic tablets, pacemakers or cranial defects and upper limb thrombosis; those with a history of seizures or family history of epilepsy; those with severe heart disease or other medical conditions; those with bleeding tendencies; those with open wounds or infections in the treatment area. 2. Patients with major depression, mania and other psychiatric diseases; 3. Patients with serious heart, lung, liver, kidney insufficiency and other complications; 4. Pregnant women and children.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer Assessment of the Upper Extremity; | — |
Secondary
| Measure | Time frame |
|---|---|
| rest motor threshold;modified Ashworth scale;Functional near-infrared spectroscopy;modified Barthel index; | — |
Countries
China
Contacts
Public ContactXiquan Hu
The Affiliated Third Hospital of Sun Yat-sen University
Outcome results
None listed